Ray Evan C, Rondon-Berrios Helbert, Boyd Cary R, Kleyman Thomas R
Renal Electrolyte Division, Department of Medicine, University of Pittsburgh, Pittsburgh, PA; and Department of Cell Biology, University of Pittsburgh, Pittsburgh, PA.
Renal Electrolyte Division, Department of Medicine, University of Pittsburgh, Pittsburgh, PA; and Department of Cell Biology, University of Pittsburgh, Pittsburgh, PA.
Adv Chronic Kidney Dis. 2015 May;22(3):179-84. doi: 10.1053/j.ackd.2014.11.006.
Sodium retention is a major clinical feature of nephrotic syndrome. The mechanisms responsible for sodium retention in this setting have been a subject of debate for years. Excessive sodium retention occurs in some individuals with nephrotic syndrome in the absence of activation of the renin-angiotensin-aldosterone system, suggesting an intrinsic defect in sodium excretion by the kidney. Recent studies have provided new insights regarding mechanisms by which sodium transporters are activated by factors present in nephrotic urine. These mechanisms likely have a role in the development of hypertension in nephrotic syndrome, where hypertension may be difficult to control, and provide new therapeutic options for the management of blood pressure and edema in the setting of nephrotic syndrome.
钠潴留是肾病综合征的主要临床特征。多年来,肾病综合征中钠潴留的机制一直是争论的焦点。在一些肾病综合征患者中,即使肾素-血管紧张素-醛固酮系统未激活,也会出现钠潴留过多的情况,这表明肾脏排钠存在内在缺陷。最近的研究为肾病综合征尿液中存在的因素激活钠转运体的机制提供了新的见解。这些机制可能在肾病综合征高血压的发生中起作用,肾病综合征中的高血压可能难以控制,这些机制还为肾病综合征患者的血压管理和水肿提供了新的治疗选择。